Dysregulation of janus kinases and signal transducers and activators of transcription in cancer.
Despite their long recognised pivotal roles in immunological responses, Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) are now seen as important players in cancer development and progression. Indeed, mutations in the JAKs are often found in myeloproliferative disorders (MPDs) and leukaemia, and the constitutive phosphorylation of STATs is a common occurrence in many solid and blood cancer cell lines and primary tumour specimens. More recently, we have also shown that JAKs likely have additional roles in promoting drug resistance in several cancer cell types. JAKs and STATs are thus molecules that may serve as useful targets in the clinic. This review will summarise studies that support this notion.
Imperial College London, Faculty of Medicine, Department of Surgery and Cancer, Hammersmith Hospital Campus Du Cane Road, London W12 0NN, United Kingdom.
Ana P
AP
Costa-Pereira
Nair A
NA
Bonito
Michael J
MJ
Seckl